tiprankstipranks
Trending News
More News >
Immunome CTO buys $103.6K in common stock
PremiumThe FlyImmunome CTO buys $103.6K in common stock
1M ago
Immunome’s Promising Pipeline and Strategic Acquisition Drive Buy Rating
Premium
Ratings
Immunome’s Promising Pipeline and Strategic Acquisition Drive Buy Rating
1M ago
Immunome’s Promising Pipeline and Strategic Advancements Support Buy Rating
Premium
Ratings
Immunome’s Promising Pipeline and Strategic Advancements Support Buy Rating
1M ago
Immunome doses first patient in IM-1021 trial
PremiumThe FlyImmunome doses first patient in IM-1021 trial
2M ago
Immunome 19.35M share Spot Secondary priced at $7.75
Premium
The Fly
Immunome 19.35M share Spot Secondary priced at $7.75
3M ago
Immunome $125M Spot Secondary; price range $7.50-$8.00
Premium
The Fly
Immunome $125M Spot Secondary; price range $7.50-$8.00
3M ago
Immunome price target lowered to $21 from $23 at Piper Sandler
PremiumThe FlyImmunome price target lowered to $21 from $23 at Piper Sandler
6M ago
Immunome, Inc. Reports Q3 2024 Financial Results
Premium
Company Announcements
Immunome, Inc. Reports Q3 2024 Financial Results
6M ago
Immunome reports Q3 EPS (78c), consensus (56c)
Premium
The Fly
Immunome reports Q3 EPS (78c), consensus (56c)
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100